A study published in CNS & Neurological Disorders – Drug Targets finds that cannabidiol (CBD) and probiotics may have complementary effects on the gut-brain axis, a communication system linking the digestive tract and central nervous system.
According to the review, the combination could hold potential for helping address conditions tied to inflammation, mood and neurological dysfunction.
The review was conducted by researchers from Amity University, who examined recent preclinical and clinical studies involving CBD, probiotics and their effects on gut microbiota, immune signaling, neurotransmitters and neuroinflammation. The researchers also looked at how the endocannabinoid system and microbiome-derived metabolites may interact in ways that influence brain function and overall neurological health.
According to the findings, both CBD and probiotics appear capable of increasing gut microbial diversity, reducing pro-inflammatory cytokines and boosting the production of neuroactive compounds such as serotonin and short-chain fatty acids. These changes may help strengthen communication between the gut and brain, including through the vagus nerve, while also influencing immune and inflammatory pathways that are tied to anxiety, depression and certain neurodegenerative disorders.
The researchers say these overlapping effects raise the possibility that CBD and probiotics may work better together than either one alone. By targeting both neurological and immunological pathways through the gut-brain axis, the combination may represent a new strategy for addressing central nervous system disorders.
At the same time, the review makes clear that the evidence remains preliminary. Although animal and laboratory findings were described as promising, the researchers say human studies are still limited in both scale and duration. They conclude that more clinical trials are needed to determine ideal dosing, long-term safety and how effective the combination may be in treating neuroimmune and neurological conditions.
Sponsored
